CHCO Short Sellers Pull Back Before Q3 Results
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
City Holding Company reports Q3 earnings today, and the most striking positioning move is a sharp retreat by short sellers in the final sessions before the print.
Short interest dropped 8.7% in a single session on October 26, falling to 967,000 shares, or 6.7% of the free float. That one-day move is roughly three standard deviations below the typical weekly swing for CHCO over the past year, making it an unusually decisive unwind rather than routine churn. The borrow market tells a different story, though: cost to borrow climbed 22.5% over the past week to 0.57%, its highest level in at least a month, even as availability remains very loose at 1,061% of short interest. With that much stock available to borrow relative to what is already shorted, the CTB move looks more like a pricing adjustment than a supply squeeze.
The stock itself barely registered the short cover, slipping 0.8% on October 27 to $141.67 and down 0.3% on the week, while the closest peers gained 2% to 5.7% across the same period. Options positioning sits slightly above its recent average, with the put/call ratio at 0.63 against a 20-day mean of 0.58, a modest tilt toward protection but nothing that signals acute stress.
Analyst coverage is cautious but warming at the margin. Keefe Bruyette and Woods raised its target to $145 earlier this month while keeping a Market Perform rating, leaving the consensus mean price target at $142.60, barely above the current price. That thin implied upside frames the bull case around execution: a 24% rise in 2025 EPS estimates over the past year, resilient net interest margins, and an asset base that reached a record high in Q2 at $6.76 billion and has grown for four consecutive quarters, according to FDIC call report data. Bears point to regulatory uncertainty around the $10 billion asset threshold, which could constrain certain revenue streams, and note that non-performing asset metrics, while stable, leave little buffer if credit conditions deteriorate.
The insider picture adds some nuance. Four directors bought small tranches at around $142 on October 23, all under pre-arranged 10b5-1 plans, a scheduled purchase rather than a discretionary signal. Against that, CEO Charles Hageboeck sold $650,000 of stock in late July, a discretionary transaction with no plan declaration. Net insider activity over the past 90 days is a disposal of roughly 4,400 shares worth $639,000. BlackRock holds 14.5% of shares and added modestly in the latest reported quarter; State Street added 102,000 shares to reach 5.4%.
Today's print will test whether CHCO's asset growth and margin resilience have continued into Q3 at the pace that drove the full-year EPS upgrade cycle, and whether the company can sustain that trajectory close enough to the $10 billion threshold to keep regulatory risk in investors' minds.
Stocks in this article
See the live data behind this article on ORTEX.
Open CHCO on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 04:17
- Data as of
- 28 Oct 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.